Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autologous Haemopoietic Stem Cell Transplant”

408 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 408 results

Early research (Phase 1)Study completedNCT00938626
What this trial is testing

Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute 12
Large-scale testing (Phase 3)Looking for participantsNCT05827016
What this trial is testing

Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 1,216
Testing effectiveness (Phase 2)Study completedNCT01718743
What this trial is testing

Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Hematopoietic Cell Transplantation RecipientPlasma Cell Myeloma
M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)Ended earlyNCT01339455
What this trial is testing

Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica

Who this might be right for
Neuromyelitis Optica
University of Calgary 3
Large-scale testing (Phase 3)Study completedNCT01241708
What this trial is testing

Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaAuto Stem Cell Transplant
Hackensack Meridian Health 148
Testing effectiveness (Phase 2)Study completedNCT01745588
What this trial is testing

Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 23
Testing effectiveness (Phase 2)Ended earlyNCT02353468
What this trial is testing

Bortezomib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Who this might be right for
Refractory Plasma Cell Myeloma
University of Colorado, Denver 3
Early research (Phase 1)Study completedNCT00652691
What this trial is testing

Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Mayo Clinic 48
Testing effectiveness (Phase 2)Study completedNCT01575860
What this trial is testing

Maintenance Lenalidomide in Lymphoma

Who this might be right for
Lymphoma
Abramson Cancer Center at Penn Medicine 8
Early research (Phase 1)Study completedNCT00574509
What this trial is testing

Hematopoietic Stem Cell Transplant for Recurrent Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska 34
Large-scale testing (Phase 3)Ended earlyNCT00083564
What this trial is testing

Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Poniard Pharmaceuticals 240
Testing effectiveness (Phase 2)Ended earlyNCT02906332
What this trial is testing

Pembrolizumab + Lenalidomide Post Autologous Stem Cell Transplant (ASCT) in High-risk Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 12
Large-scale testing (Phase 3)Study completedNCT00477971
What this trial is testing

Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 89
Testing effectiveness (Phase 2)Study completedNCT00003199
What this trial is testing

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerEstrogen Receptor-positive Breast CancerInflammatory Breast Cancer+5 more
Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT07236151
What this trial is testing

Sequential CD19/CD22 CAR-T Cell Therapy Following ASCT

Who this might be right for
Large B-cell LymphomaCAR T Cell TherapyAuto Stem Cell Transplant
The First Affiliated Hospital of Soochow University 23
Testing effectiveness (Phase 2)Study completedNCT03159845
What this trial is testing

Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
Stem Cell Transplant Complications
Azienda Ospedaliero, Universitaria Pisana 20
Early research (Phase 1)Ended earlyNCT02483000
What this trial is testing

Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies

Who this might be right for
Burkitt LymphomaCD20-Positive Neoplastic Cells PresentDiffuse Large B-Cell Lymphoma+4 more
Fred Hutchinson Cancer Center 3
Not applicableStudy completedNCT04760405
What this trial is testing

The TOTOM Trial: Tai Chi to Optimize Transplant Outcomes for Multiple Myeloma

Who this might be right for
Multiple MyelomaStem Cell Transplant Complications
University of Arizona 12
Early research (Phase 1)WithdrawnNCT02378922
What this trial is testing

Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma

Who this might be right for
AIDS-Related Hodgkin LymphomaAIDS-Related Non-Hodgkin LymphomaHIV Infection+2 more
Fred Hutchinson Cancer Center
Not applicableUnknownNCT02087657
What this trial is testing

Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplantation

Who this might be right for
Multiple MyelomaHodgkin's DiseaseNon-Hodgkin's Lymphoma
University of Kansas Medical Center 20
Load More Results